InsiderClue
Insiders · Profile

Kumar Ramesh

Director at Ocugen · President and CEO at Traws Pharma. Filing since 7 Feb 2013. CIK 0001580074

OCGN Ocugen, Inc. Director · 7 trades TRAW Traws Pharma, Inc. President and CEO · 8 trades
Company
Date
Role
Action
Shares
Amount
Of holding
OCGN Ocugen, Inc.
6 Oct 2022
Director
Sold, plan not stated
4,500
$8.24K
100%
OCGN Ocugen, Inc.
18 Jul 2022
Director
Sold, plan not stated
7,500
$19.28K
100%
OCGN Ocugen, Inc.
18 Apr 2022
Director
Sold, plan not stated
7,500
$21.23K
100%
OCGN Ocugen, Inc.
18 Jan 2022
Director
Sold, plan not stated
7,500
$30.53K
100%
OCGN Ocugen, Inc.
18 Oct 2021
Director
Sold, plan not stated
7,500
$60.98K
100%
OCGN Ocugen, Inc.
19 Jul 2021
Director
Sold, plan not stated
7,500
$48.00K
100%
OCGN Ocugen, Inc.
19 Apr 2021
Director
Sold, plan not stated
7,500
$39.98K
100%
TRAW Traws Pharma, Inc.
26 Apr 2017
President and CEO
Bought
23,810
$50.00K
30.4%
TRAW Traws Pharma, Inc.
10 Feb 2014
President and CEO
Sold, plan not stated
20,000
$302.20K
6.7%
TRAW Traws Pharma, Inc.
3 Feb 2014
President and CEO
Sold, plan not stated
20,000
$301.40K
6.7%
TRAW Traws Pharma, Inc.
31 Jan 2014
President and CEO
Sold, plan not stated
20,000
$300.60K
6.7%
TRAW Traws Pharma, Inc.
30 Jan 2014
President and CEO
Sold, plan not stated
20,000
$301.00K
6.7%
TRAW Traws Pharma, Inc.
15 Nov 2013
President and CEO
Bought
1,100
$13.22K
0.4%
TRAW Traws Pharma, Inc.
30 Jul 2013
President and CEO
Bought
6,667
$100.01K
2.5%
TRAW Traws Pharma, Inc.
7 Feb 2013
President and CEO
Sold, plan not stated
13,543
$203.42K
4.7%
15 decisions on file.